ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2020

HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window.

Junli Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.